M. Citron

发表

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

E. Mardis, C. Perou, M. Ellis, 2016, npj Breast Cancer.

Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline.

E. Bruera, M. Citron, L. Constine, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

D. Berry, E. Winer, E. Perez, 2006, JAMA.

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

Barbara L. Smith, Robert Livingston, Richard L Schilsky, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Predicting response and survival in chemotherapy-treated triple-negative breast cancer

E Mardis, E. Mardis, C. Fan, 2014, British Journal of Cancer.

Assessment of chlorinated pesticides and polychlorinated biphenyls in adipose breast tissue using a supercritical fluid extraction method.

M. Citron, S. Stellman, M. Djordjevic, 1994, Carcinogenesis.

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

Donald A. Berry, Eric P. Winer, Larry Norton, 2006 .

Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine.

M. Prados, S. Coons, M. Citron, 1996, Cancer research.

O6-methylguanine-DNA methyltransferase in human normal and tumor tissue from brain, lung, and ovary.

M. Citron, D. Yarosh, R. Decker, 1991, Cancer research.

Can we really use retrospective subset analyses and surveillance, epidemiology, and end results data to drive clinical practice?

E. Winer, C. Hudis, M. Citron, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B Experience.

D. Berry, E. Winer, C. Hudis, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dose-Dense Adjuvant Chemotherapy for Breast Cancer

M. Citron, JoAnne Ziegler, 2006, Cancer nursing.

Dose Density in Adjuvant Chemotherapy for Breast Cancer

M. Citron, 2004, Cancer investigation.

Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer.

M. Citron, J. Cohen, Jon R. Cohen, 1991, Surgery.

Isolated sternal involvement in breast cancer: is it truly stage IV disease?

M. Citron, Yiwu Huang, A. Astrow, 2011, Clinical breast cancer.

Dose-dense (DD) AC followed by paclitaxel is associated with moderate, frequent anemia compared to sequential (S) and/or less DD Treatment: Update by CALGB on Breast Cancer Intergroup Trial C9741 with ECOG, SWOG, & NCCTG

D. Berry, E. Winer, E. Perez, 2005 .

O6-methylguanine-DNA methyltransferase in normal and malignant tissue of the breast.

M. Citron, D. Yarosh, P. Wasserman, 1994, Cancer investigation.

Modulation of human tumor colony growth in soft agar by serum.

M. Citron, A. Hamburger, C. White, 1983, International journal of cell cloning.

Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York.

M. Citron, M. Kemeny, J. Britton, 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Risk of lung carcinoma among users of nonsteroidal antiinflammatory drugs

A. Neugut, M. Citron, N. Altorki, 2003, Cancer.

Older‐Patient‐Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)

H. Cohen, M. Citron, L. Carey, 2019, The oncologist.

Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts.

A. Neugut, M. Citron, R. Santella, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives

M. Citron, 2008, Breast Care.

Dose-dense chemotherapy for node-positive breast cancer.

M. Citron, 2005, Annals of internal medicine.

Continuous Intravenous Infusion of Morphine for Severe Dyspnea

M. Citron, S. Spagnolo, M. Cohen, 1991, Southern medical journal.

Inhibition of Staphylococcus aureus Biofilms by a Novel Antibacterial Envelope for Use with Implantable Cardiac Devices

M. Citron, O. Wazni, G. James, 2009, Clinical and translational science.

Secretin/vasoactive intestinal peptide-stimulated secretion of bombesin/gastrin releasing peptide from human small cell carcinoma of the lung.

M. Citron, T. Moody, D. Carney, 1986, Cancer research.

Thrombosis: the major Hickman catheter complication in patients with solid tumor.

L. G. Ortega, M. Citron, Martin H. Cohen, 1989, Chest.

Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice.

M. Citron, D. Mitchell, D. Yarosh, 1992, Cancer research.

Placebos and Principles: A Trial of Ondansetron

M. Citron, M. L. Citron, 1993, Annals of Internal Medicine.

Safety and efficacy of continuous intravenous morphine for severe cancer pain.

M. Citron, S. Spagnolo, M. Cohen, 1984, The American journal of medicine.

Abstract P2-10-01: PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy

E. Mardis, C. Perou, E. Winer, 2012 .

Dihydro‐5‐azacytidine in malignant mesothelioma

M. Citron, J. Herndon, Mark R. Green, 1997, Cancer.

Non-Hodgkin's lymphoma during pregnancy.

M. Citron, M. Spitzer, M. Citron, 1991, Gynecologic oncology.

Intracellular localization and intercellular heterogeneity of the human DNA repair protein O6-methylguanine-DNA methyltransferase

M. Citron, M. Dolan, D. Yarosh, 1996, Cancer Chemotherapy and Pharmacology.

Efficacy of local rifampin/minocycline delivery (AIGIS(RX)®) to eliminate biofilm formation on implanted pacing devices in a rabbit model.

M. Citron, M. Sanders, K. Berg, 2010, The International journal of artificial organs.

Calcified pulmonary metastases from medullary carcinoma of the thyroid.

M. Citron, J. M. Jiménez, A. Khan, 1995, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

Analysis of O6-methylguanine-DNA methyltransferase in individual human cells by quantitative immunofluorescence microscopy.

M. Citron, B. F. Li, T. Ayi, 1994, Oncology research.

Improvement of human tumor cloning assay by suspension of fibroblasts into the bottom layer of agarose

M. Citron, A. Hamburger, M. Cohen, 1986, Cancer.

Pharmacokinetic comparison of intranasal, oral, and intramuscular metoclopramide in healthy volunteers.

M. Citron, F. Miller, J. Kalra, 1987, Cancer treatment reports.

Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.

M. Citron, W. Parris, B. Buckley, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer

Mary Beth Terry, Regina M. Santella, Jan Beyea, 2002, Breast Cancer Research and Treatment.

O6-methylguanine-DNA methyltransferase in human normal and malignant lung tissues.

M. Citron, D. Yarosh, M. Lewis, 1993, Cancer investigation.

O6-methylguanine-DNA methyltransferase in ovarian malignancy and its correlation with postoperative response to chemotherapy.

M. Citron, D. Yarosh, G. Spiegel, 1992, Gynecologic oncology.

Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood.

Geoffrey C Kabat, Mary Beth Terry, Steven D Stellman, 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Lung cancer risk in white and black Americans.

A. Neugut, M. Citron, N. Altorki, 2003, Annals of epidemiology.

Smoking and lung cancer risk in American and Japanese men: an international case-control study.

S D Stellman, T Takezaki, H Ogawa, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study

M. Citron, S. Weinstein, B. Buckley, 1998, European journal of pain.

Patient-controlled analgesia for severe cancer pain.

M. Citron, M. Cohen, S. Krasnow, 1986, Archives of internal medicine.

Sixteen-week multidrug regimen versus cyclophosphamide, doxorubicin, and fluorouracil as adjuvant therapy for node-positive, receptor-negative breast cancer: an Intergroup study.

R. Gray, M. Citron, N. Robert, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of high-dose 24-hour continuous intravenous 5-fluorouracil for advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.

M. Citron, K. Propert, M. Green, 1992, Cancer investigation.

Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancer.

M. Citron, M. Campone, L. Dirix, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor seeding associated with bone marrow aspiration and biopsy.

M. Citron, M. Cohen, S. Krasnow, 1984, Archives of internal medicine.

Management of Gastric and Pancreatic Cancer

M. Citron, J. Macdonald, F. Smith, 1980 .

O6-methylguanine-DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies.

M. Citron, D. Yarosh, R. Decker, 1995, Oncology research.

Combined therapy for stage III-IV head and neck cancer: preliminary results.

M. Citron, H. deFries, M. Cohen, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.

M. Citron, J. Abrams, C. Cirrincione, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of Local Rifampin/Minocycline Delivery (AIGISRX®) to Eliminate Biofilm Formation on Implanted Pacing Devices in a Rabbit Model

M. Citron, M. Sanders, K. Berg, 2010, The International journal of artificial organs.

Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York.

M. Citron, M. Kemeny, J. Britton, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Breast Cancer Risk in Relation to Adipose Concentrations of Organochlorine Pesticides and Polychlorinated Biphenyls in Long Island , New York 1

M. Citron, M. Kemeny, J. Britton, 2000 .

Relative abundance of organochlorine pesticides and polychlorinated biphenyls in adipose tissue and serum of women in Long Island, New York.

S D Stellman, M. Citron, M. Kemeny, 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Long-term administration of controlled-release oxycodone tablets for the treatment of cancer pain.

M. Citron, W. Parris, R. Rosenbluth, 1998, Cancer investigation.

O 6-Methylguanine-DNA Methyltransferase in Human Normal and Tumor Tissue from Brain , Lung , and Ovary 1

M. Citron, D. Yarosh, R. Decker, 2006 .

A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma.

M. Citron, D. Levitt, J. Zeffren, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

5-Fluorouracil pharmacokinetics in patients with metastatic colorectal carcinoma after high-dose leucovorin.

M. Citron, B. Bailey, T. Stein, 1994, Cancer investigation.

Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey

M. Citron, A. Brufsky, Catherine Ormerod, 2017, The breast journal.

Exploration of communication gaps among women with metastatic breast cancer, caregivers and oncologists

M. Citron, A. Brufsky, M. Mayer, 2016 .

Drug precipitation within i.v. tubing: a potential hazard of chemotherapy administration.

M. Citron, M. Cohen, S. Krasnow, 1985, Cancer treatment reports.

A pharmacodynamic study of morphine and its glucuronide metabolites after single morphine dosing in cancer patients with pain.

M. Citron, C. Fanelli, M. Lesser, 1997, Cancer investigation.

Intramedullary spinal cord metastases treated by complete resection of tumor prior to radiotherapy and chemotherapy. Case report and review.

M. Citron, R. Decker, S. Sundrani, 1987, Spine.